Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine.
about
Examining How Our Shared Evolutionary History Shapes Future Disease Outcomes.Recent developments and future directions for the use of pharmacogenomics in cardiovascular disease treatments.Metabolomics and Biomarkers for Drug Discovery.Effect of cytochrome P450 2C19 polymorphism on adverse cardiovascular events after drug-eluting stent implantation in a large Hakka population with acute coronary syndrome receiving clopidogrel in southern China.The Alpha-2A Adrenergic Receptor Gene -1291C/G Single Nucleotide Polymorphism is Associated with the Efficacy of Methylphenidate in Treating Taiwanese Children and Adolescents with Attention-Deficit Hyperactivity Disorder.Emerging Role of Precision Medicine in Cardiovascular Disease.Precision cardio-oncology: understanding the cardiotoxicity of cancer therapy.
P2860
Q30235244-3521B8AC-2795-4CDD-A25E-A2EDD40CFB4BQ38644870-ED81FE8F-2FE6-4060-8D9D-ACC16EBAE450Q48134280-90AA5768-3A9B-4E2B-BD86-E7A30C85093CQ49833189-636689DC-1EF2-4A70-8AF4-68F6C865869DQ51746911-3C97FB97-BCF2-4543-A7FA-DD6D0B6C391AQ53748314-1987CFE2-4479-4CB1-902F-418C73792B76Q54976923-73DF72DD-6E81-46C8-BF4C-62E97830CEB4
P2860
Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Cardiovascular pharmacogenetic ...... apy and personalized medicine.
@en
type
label
Cardiovascular pharmacogenetic ...... apy and personalized medicine.
@en
prefLabel
Cardiovascular pharmacogenetic ...... apy and personalized medicine.
@en
P2860
P356
P1433
P1476
Cardiovascular pharmacogenetic ...... apy and personalized medicine.
@en
P2093
P2860
P304
P356
10.1111/CGE.12881
P577
2016-10-06T00:00:00Z